Amylyx prices newly approved ALS drug at $158,000 per year

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. OKTA
3. CRM
4. CRWD
5. VEEV
6. KKR
7. NTNX
8. P
9. HPQ
10. A

Go back to Amylyx prices newly approved ALS drug at $158,000 per year
(NASDAQ: AMLX) Delayed: 37.08 --0 (-0%)
Previous Close $37.08    52 Week High $ 
Open $37.08    52 Week Low $ 
Day High $37.08    P/E N/A 
Day Low $37.08    EPS $ 
Volume 5,043